Advik Laboratories MD, chairman, board of directors and AGM
BSE: 531686Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 19 Oct 2026. Previous close ₹2.08.
- Under BSE's graded surveillance, stage IV, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3.98 Cr5,167th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 58.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- −180.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −14.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 109.84
- Volume, BSEVolume. Shares traded on the last trading day.
- 300
Advik Laboratories board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorPEEYUSH KUMAR AGGARWALRelated to the promoter
- Company Secretary and Compliance OfficerPOOJA CHUNI
4 directors2 independent1 executive1 non-executive
- PEEYUSH KUMAR AGGARWAL · Chairperson and managing directorExecutive · joined Jul 2013 · reappointed Sep 2025 · 4 listed boards · 6 committee seats
- AJAY SHARMAIndependent · joined Jul 2023 · reappointed Sep 2023 · 60 months as independent · 2 listed boards · 2 as independent · 1 committee seat, 2 as chair
- MADHU SHARMAIndependent · joined Jan 2017 · reappointed Jan 2022 · 60 months as independent · 4 listed boards · 3 as independent · 3 committee seats, 2 as chair
- RAM NIWAS SHARMANon-executive · joined Aug 2019 · reappointed Sep 2024 · 1 listed board
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 28 May 20264 of 4 present2 independent · 85 days in between
- 3 Mar 20264 of 4 present2 independent
- 2 Feb 20264 of 4 present2 independent
Audit Committee
Chair MADHU SHARMA
PEEYUSH KUMAR AGGARWAL, AJAY SHARMA
- 28 May 20263 of 3 present2 independent · 85 days in between
- 3 Mar 20263 of 3 present2 independent
- 2 Feb 20263 of 3 present2 independent
Nomination and remuneration committee
Chair AJAY SHARMA
RAM NIWAS SHARMA, MADHU SHARMA
- 3 Mar 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair RAM NIWAS SHARMA
PEEYUSH KUMAR AGGARWAL, MADHU SHARMA
- 13 Apr 20263 of 3 present1 independent · 85 days in between
- 17 Jan 20263 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- NEMANI GARG AGARWAL AND CO.Peer-review certificate valid to Jul 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Advik Laboratories AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Advik Laboratories share news and announcements
Annual general meeting, 29 Sep 2026
4,397 shareholders on the register on 22 Sep 2026; present: 2 promoters and 37 others; votes counted by KUNDAN AGRAWAL / KUNDAN AGRAWAL AND ASSOCIATES.The company's voting result (opens in a new tab)
To receive, consider and adopt the Audited Financial Statements of the company including the Balance Sheet of the Company as at 31st March, 2026 and the Statement of Profit and Loss of the Company for the Financial Year ended 31st March, 2026 together with the Cash Flow Statement & other Annexures thereof and the Report of the Board of Directors and Auditors thereonMoreLess
Ordinary99.99% for0.01% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 65.40% · promoters 100.00% · institutions 0.00% · other public 46.03%
To appoint a Director in place of Mr. Ram Niwas Sharma (DIN:08427985), who is liable to retire by rotation and being eligible, offers himself for re-appointment pursuant to the provisions of Section 152 of the Companies Act, 2013MoreLess
Ordinary99.99% for0.01% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 65.40% · promoters 100.00% · institutions 0.00% · other public 46.03%
- Re-appointment of M/s Nemani Garg Agarwal & Co., Chartered Accountants as the Statutory Auditors of the CompanyOrdinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 65.40% · promoters 100.00% · institutions 0.00% · other public 46.03%
- Approval for Related Party Transactions under Section 188 of the Companies Act, 2013 and Regulation 23 of SEBI (LODR) Regulations, 2015OrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 29.49% · promoters 0.00% · institutions 0.00% · other public 46.01%
- Appointment of Ms. Anchal Goyal (DIN 10751205) as an Independent Director of the CompanySpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 65.39% · promoters 100.00% · institutions 0.00% · other public 46.01%
- Approval Of Transactions Under Section 185 Of The Companies Act, 2013SpecialPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 29.50% · promoters 0.00% · institutions 0.00% · other public 46.01%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Fines
Reported in the filing for the quarter to Jun 2026.
- Fine or penaltyBSE LIMITEDSince 12 Jul 2022
Restriction of trading of scrip of the Company on account of GSM 4 framework & freezing of demat account of promoters
The company has defaulted in payment of Annual Listing Fees to BSE as per Regulation 14 of the SEBI (Listing Obligations and Disclosure Requirements), 2015. And, therefore, BSE has put the scrip of the company under GSM 3 framework & freezed the demat account of its promoters due to non-payment of annual listing fees. However, BSE vide its notice no. 20210219-31 dated 19 Feb, 2021 has allowed the trading of shares of the company on Trade-for-Trade basis only on the first trading day of every week till the company makes payment of outstanding ALF to the Exchange.MoreLess
- Fine or penaltyBSE LIMITEDSince 17 May 2023
Suspension/Restriction of trading of scrip of the Company
The company has defaulted in payment of Annual Listing Fees to BSE as per Regulation 14 of the SEBI (Listing Obligations and Disclosure Requirements), 2015. And, therefore, BSE has suspended/restricted the trading of the scrip of the company on BSE’s web portal due to non-payment of annual listing fees. However, BSE vide its notice no. 20210219-31 dated 19 Feb, 2021 has allowed the trading of shares of the company on Trade-for-Trade basis only on the first trading day of every week till the company makes payment of outstanding ALF to the Exchange.MoreLess
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- No
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.